UBS Group’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $247K | Buy |
|
|||||
|
2025
Q2 | $64.7K | Sell |
|
|||||
|
2025
Q1 | $145K | Buy |
|
|||||
|
2024
Q4 | $11.1K | Buy |
|
|||||
|
2024
Q3 | $3.27K | Sell |
|
|||||
|
2024
Q2 | $3.43K | Sell |
|
|||||
|
2024
Q1 | $73.9K | Sell |
|
|||||
|
2023
Q4 | $1.89M | Buy |
|
|||||
|
2023
Q3 | $86.6K | Buy |
|
|||||
|
2023
Q2 | $82.7K | Sell |
|
|||||
|
2023
Q1 | $970K | Sell |
|
|||||
|
2022
Q4 | $1.17M | Buy |
|
|||||
|
2022
Q3 | $325K | Buy |
|
|||||
|
2022
Q2 | $318K | Sell |
|
|||||
|
2022
Q1 | $2.32M | Buy |
|
|||||
|
2021
Q4 | $3.87M | Buy |
|
|||||
|
2021
Q3 | $2.42M | Buy |
|
|||||
|
2021
Q2 | $494K | Sell |
|
|||||
|
2021
Q1 | $1.47M | Buy |
|
|||||
|
2020
Q4 | $65K | Sell |
|
|||||
|
2020
Q3 | $49K | Sell |
|
|||||
|
2020
Q2 | $72K | Sell |
|
|||||
|
2020
Q1 | $85K | Sell |
|
|||||
|
2019
Q4 | $621K | Sell |
|
|||||
|
2019
Q3 | $621K | Buy |
|
|||||
|
2019
Q2 | $70K | Buy |
|
|||||
|
2019
Q1 | $66K | Sell |
|
|||||
|
2018
Q4 | $80K | Sell |
|
|||||
|
2018
Q3 | $760K | Buy |
|
|||||
|
2018
Q2 | $30K | Sell |
|
|||||
|
2018
Q1 | $4.02M | Buy |
|
|||||
|
2017
Q4 | $23K | Buy |
|
|||||
|
2017
Q3 | $17K | Buy |
|
|||||
|
2017
Q2 | $0 | Hold |
|
|||||
|
2017
Q1 | $0 | Sell |
|
|||||
|
2016
Q4 | $120K | Buy |
|
|||||
|
2016
Q3 | $148K | Sell |
|
|||||
|
2016
Q2 | $169K | Buy |
|
|||||
|
2016
Q1 | $136K | Sell |
|
|||||
|
2015
Q4 | $925K | Buy |
|
|||||
|
2015
Q3 | $116K | Buy |
|
|||||
|
2015
Q2 | $158K | Buy |
|
|||||
|
2015
Q1 | $42K | Sell |
|
|||||
|
2014
Q4 | $29K | Buy |
|